The July AIFMD Annex IV reporting deadline has passed, and for many AIFMs across Europe and the UK, the pressure drops as another regulatory hurdle has been cleared. But a deeper question (re)emerges: was this process truly efficient, or did it expose underlying challenges that will resurface with the next reporting cycle?